Citadel Advisors’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-100
Closed -$2.46K 13878
2025
Q1
$2.46K Sell
100
-200
-67% -$4.94K ﹤0.01% 14036
2024
Q4
$6.95K Hold
300
﹤0.01% 13771
2024
Q3
$8.13K Buy
300
+200
+200% +$6.06K ﹤0.01% 13320
2024
Q2
$2.88K Sell
100
-11,200
-99% -$343K ﹤0.01% 13646
2024
Q1
$330K Buy
11,300
+9,200
+438% +$257K ﹤0.01% 9252
2023
Q4
$68.3K Sell
2,100
-1,000
-32% -$29K ﹤0.01% 11420
2023
Q3
$99.2K Buy
3,100
+1,800
+138% +$69.3K ﹤0.01% 10906
2023
Q2
$57K Sell
1,300
-1,000
-43% -$46.1K ﹤0.01% 11651
2023
Q1
$102K Sell
2,300
-800
-26% -$35.4K ﹤0.01% 11237
2022
Q4
$123K Sell
3,100
-13,200
-81% -$550K ﹤0.01% 10916
2022
Q3
$752K Buy
+16,300
New +$799K ﹤0.01% 7608
2022
Q2
Sell
-7,700
Closed -$416K 13522
2022
Q1
$416K Buy
+7,700
New +$393K ﹤0.01% 9809
2021
Q3
Sell
-3,600
Closed -$227K 14257
2021
Q2
$227K Sell
3,600
-11,100
-76% -$638K ﹤0.01% 11886
2021
Q1
$717K Sell
14,700
-16,300
-53% -$782K ﹤0.01% 8888
2020
Q4
$1.28M Buy
31,000
+23,700
+325% +$1.09M ﹤0.01% 6264
2020
Q3
$335K Sell
7,300
-5,300
-42% -$246K ﹤0.01% 7944
2020
Q2
$551K Buy
+12,600
New +$567K ﹤0.01% 6905

Other funds holding KIDS

Citadel Advisors's KIDS Position: Q1 2026 in Review

Citadel Advisors increased its OrthoPediatrics (KIDS) stake by 21% in Q1 2026, buying an estimated $573K and bringing the position to 185,393 shares worth $2.94M. The position accounts for ﹤0.01% of the portfolio, ranked #5302.

Citadel Advisors first reported a position in KIDS in Q1 2019 and has held it in 27 quarters since. The position peaked at $5.8M in Q4 2020. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.

  • Citadel Advisors held 185,393 shares of OrthoPediatrics worth $2.94M as of Q1 2026.
  • Citadel Advisors bought 32,782 OrthoPediatrics shares in Q1 2026, an estimated $573K.
  • OrthoPediatrics made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5302 holding.
  • Citadel Advisors first reported a position in OrthoPediatrics in Q1 2019 and has held it in 27 quarters since.
  • Citadel Advisors's OrthoPediatrics position peaked at $5.8M in Q4 2020.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.